2 results match your criteria: "Unversity College London[Affiliation]"
Syst Rev
December 2022
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, Unversity College London, 90 High Holborn, London, WC1V 6LJ, UK.
Background: Research overlap and duplication is a recognised problem in the context of both pairwise and network systematic reviews and meta-analyses. As a case study, we carried out a scoping review to identify and examine duplicated network meta-analyses (NMAs) in a specific disease setting where several novel therapies have recently emerged: hormone-sensitive metastatic prostate cancer (mHSPC).
Methods: MEDLINE and EMBASE were systematically searched, in January 2020, for indirect or mixed treatment comparisons or network meta-analyses of the systemic treatments docetaxel and abiraterone acetate in the mHSPC setting, with a time-to-event outcome reported on the hazard-ratio scale.
J Photochem Photobiol B
August 2021
Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET-Hospital de Clínicas Gral, José de San Martín, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address:
The delta-amino acid 5-aminolevulinic acid (ALA), is the precursor of the endogenous photosensitiser Protoporphyrin IX (PpIX), and is currently approved for Photodynamic Therapy (PDT) of certain superficial cancers. However, ALA-PDT is not very effective in diseases in which T-cells play a significant role. Cutaneous T-cell lymphomas (CTCL) is a group of non-Hodgkin malignant diseases, which includes mycosis fungoides (MF) and Sézary syndrome (SS).
View Article and Find Full Text PDF